Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.


Product Name:                  4,6-Dichloro-5-nitro-2-propylthiopyrimidine

Synonyms:                         N/A

CAS Number:                     145783-14-8

Molecular Weight:            268.1172

Molecular Formula:          C7H7Cl2N3O2S

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CCCSc1nc(Cl)c(c(n1)Cl)[N+](=O)[O-]


  • $69.00
  • Ex Tax: $69.00

Available Options